DYN Dynegy Inc.

Dynegy Closes on Brayton Point Sale

Dynegy Inc. (NYSE: DYN) has completed the sale of its 307-acre site of the former Brayton Point Power Station in Somerset, Mass. to Commercial Development Company, Inc.

The previously disclosed transaction includes Commercial Development Company’s assumption of environmental responsibilities associated with the site. The Brayton Point facility was one of 10 power generation facilities purchased by Dynegy from Energy Capital Partners in April 2015. The decision to retire the 1,488-megawatt, coal-fueled facility, which was commissioned in 1963, was made prior to Dynegy’s purchase of the facility. The plant ceased operations at the end of May 2017.

About Dynegy

Throughout the Northeast, Mid-Atlantic, Midwest, Texas, and California, Dynegy operates more than 27,000 megawatts (MW) of power generating facilities capable of producing enough energy to supply more than 23 million American homes. Through our retail business, we serve 1.2 million customers who depend on reliable, affordable energy to grow and thrive.

EN
22/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dynegy Inc.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 26, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: July 19, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 15, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Dyne Therapeutics Inc: 1 director

A director at Dyne Therapeutics Inc bought 100,000 shares at 9.110USD and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch